Furthermore, although a small portion of the RA sera was monospecific, 50% of the RA sera reacted with more than two citrullinated EBNA-1 peptides, confirming the theory of overlapping and non-overlapping ACPA reactivities [47,79]. The gene discussed is PRTN3; the disease is rheumatoid arthritis.